Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 551-559 , July 2009

Quantitative small animal PET imaging with nonconventional nuclides

Received 20 October 2008 ,Revised 20 December 2008 ,Accepted 27 January 2009.

References 

  1. Williams H, Robinson S, Julyan P, Zweit J, Hastings D. A comparison of PET imaging characteristics of various copper radioisotopes. Eur J Nucl Med Mol Imag. 2005;32(12):1473–1480
  2. Smith SV. Molecular imaging with copper-64. J Inor Biochem. 2004;98(11):1874–1901
  3. Lewis JS, Laforest R, Buettner TL, Song SK, Fujibayashi Y, Connet JM, et al. Copper-64-diacetyl-bis(N4-methylthiosemicarbazone): an agent for radiotherapy. Proc Nucl Acad Scie. 2001;98(3):1206–1211
  4. Dehdashti F, Grigsby PW, Lewis JS, Laforest R, Siegel BA, Welch MJ. Assessing tumor hypoxia in cervical cancer by PET with 60Cu-labeled diacetyl-bis(N4-methylthiosemicarbazone). J Nucl Med. 2008;49(2):201–205
  5. Ruangma A, Bai B, Lewis JS, Sun X, Welch MJ, Leahy RM, et al. Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides. Nucl Med Biol. 2006;33:217–226
  6. Smith-Jones PM, Stolz B, Bruns C, Albert R, Reist H, Fridrich R, et al. Gallium-67/gallium-68-[DFO]-octreotide — a potential radiopharmaceutical for PET imaging of somatostatin receptor-positive tumors: synthesis and radiolabeling in vitro and preliminary in vivo studies. J Nucl Med. 1994;35(2):317–325
  7. Barker WC, Szajek LP, Green SL, Carson RE. Improved quantification for Tc-94m PET imaging. IEEE Trans Nucl Sci. 2001;48(3):739–742
  8. Dupont S, Semah F, Loc'h C, Strijckmans V, Baulac M, Samson Y, et al. In vivo imaging of muscarinic cholinergic receptors in temporal lobe epilepsy with a new PET tracer: [76Br]4-bromodexetimide. J Nucl Med. 1999;40(6):935–941
  9. Lovqvist A, Lundqvist H, Lubberink M, Tolmachev V, Carlsson J, Sundin A. Kinetics of [sup 76]Br-labeled anti-CEA antibodies in pigs; aspects of dosimetry and PET imaging properties. Med Phys. 1999;26(2):249–258
  10. Ribeiro MJ, Almeida P, Strul D, Ferreira N, Loc'h C, Brulon Vt, et al. Comparison of fluorine-18 and bromine-76 imaging in positron emission tomography. Eur J Nucl Med Mol Imag. 1999;26(7):758–766
  11. Lubberink M, Schneider H, Bergstromm M, Lundqvist H. Quantitative imaging and correction for cascade gamma radiation of 76Br with 2D and 3D PET. Phys Med Biol. 2002;47(19):3519
  12. Lovqvist A, Humm JL, Sheikh A, Finn RD, Koziorowski J, Ruan S, et al. PET imaging of 86Y-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: comparison between 86Y and 111In radiolabels. J Nucl Med. 2001;42(8):1281–1287
  13. Herzog H, Rosch F, Stocklin G, Lueders C, Qaim SM, Feinendegen LE. Measurement of pharmacokinetics of yttrium-86 radiopharmaceuticals with PET and radiation dose calculation of analogous yttrium-90 radiotherapeutics. J Nucl Med. 1993;34(12):2222–2226
  14. Walrand S, Jamar F, Mathieu I, De Camps J, Lonneux M, Sibomana M, et al. Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86. Eur J Nucl Med Mol Imag. 2003;30(3):354–361
  15. Pagani M, Stone-Elander S, Larsson SA. Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applications. Eur J Nucl Med Mol Imaging. 1997;24(10):1301–1327
  16. Pentlow KS, Graham MC, Lambrecht RM, Cheung NKV, Larson SM. Quantitative imaging of I-124 using positron emission tomography with applications to radioimmunodiagnosis and radioimmunotherapy. Med Phys. 1991;18(3):357–366
  17. Flower MA, Al-Saadi A, Harmer CL, McCready VR, Ott RJ. Dose-response study on thyrotoxic patients undergoing positron emission tomography and radioiodine therapy. Eur J Nucl Med Mol Imaging. 1994;21(6):531–536
  18. Gonzalez Trotter DE, Manjeshwar RM, Doss M, Shaller C, Robinson MK, Tandon R, et al. Quantitation of small-animal 124I activity distributions using a clinical PET/CT scanner. J Nucl Med. 2004;45(7):1237–1244
  19. Laforest R, Rowland DJ, Welch MJ. MicroPET imaging with nonconventional isotopes. IEEE Trans Nucl Sci. 2002;49(5):2119–2126
  20. Schueller MJ, Mulnix TL, Christian BT, Jensen M, Holm S, Oakes TR, et al. Addressing the third gamma problem in PET. IEEE Trans Nucl Sc. 2003;50(1):50–52
  21. Martin CC, Christian BT, Satter MR, Nickerson LDH, Nickles RJ. Quantitative PET with positron emitters that emit prompt gamma rays. IEEE Trans Med Imaging. 1995;14(4):681–687
  22. Pentlow KS, Finn RD, Larson SM, Erdi YE, Beattie BJ, Humm JL. Quantitative imaging of yttrium-86 with PET: the occurrence and correction of anomalous apparent activity in high density regions. Clin Pos Ima. 2000;3:85–90
  23. Kohlmyer SG, Miyaoka RS, Shoner SC, Lewellen TK, Eary JF. Quantitative accuracy of PET imaging with yttrium-86. J Nucl Med. 1999;40(5):280P
  24. Lubberink M, et al. Correction for gamma radiation from non-pure positron emitters in positron emission tomography. In: Future Directions in Nuclear Medicine Physics and Engineering. Chicago: The University of Chicago; 1999;
  25. Herzog H, Tellmann L, Qaim SM, Spellerberg S, Schmid A, Coenen HH. PET quantitation and imaging of the non-pure positron emitting iodine isotope I-124. Appl Radiat Isot. 2002;56(5):673–679
  26. Laforest R, Longford D, Siegel S, Newport DF, Yap J. Performance evaluation of the microPET (R)-FOCUS-F120. IEEE Trans Nucl Sci. 2007;54(1):42–49
  27. Tai YC, Ruangma A, Rowland D, Siegel S, Newport D, Chow P, et al. Performance evaluation of microPET focus: a third generation microPET Scanner dedicated to animal imaging. J Nucl Med. 2005;45:455–463
  28. McCarthy DW, Bass LA, Cutler PD, Shefer RE, Klinkowstein RE, Herrerro P, et al. High purity production and potential applications of copper-60 and copper-61. Nucl Med Biol. 1999;26:351–358
  29. Biggot H, Laforest R, Liu X, Ruangma A, Wuest F, Welch MJ. Advances in the production, processing and microPET image quality of technetium-94m. Nucl Med Biol. 2006;33:923–933
  30. Yoo J, Tang L, Perkins TA, Rowland DJ, Laforest R, Lewis JS, et al. Preparation of high specific activity (86)Y using a small biomedical cyclotron. Nucl Med Biol. 2005;32(8):891–897
  31. NNDC (National Nuclear Data Center) . Medical internal radiation dosimetry. http://www.nndc.bnl.gov/mird/
  32. Laforest R, Liu X. Image quality with non-standard nuclides in PET. Q J Nucl Med Mol Imaging. 2008;52:151–158
  33. Beattie BJ, Pentlow KS, Finn RD, Larson SM. A method for the removal of spurious activity in PET imaging introduced by cascade gamma rays. J Nucl Med. 2001;42(5):201P
  34. Hudson HM, Larkin LS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging. 1994;13(4):601–609
  35. Qi J, Leahy RM, Cherry SR, Chatziioannou A, Farquhar TH. High-resolution 3D Bayesian image reconstruction using the microPET small-animal scanner. Phys Med Biol. 1998;43:1001–1013
  36. Chatziioannou A, Qi J, Moore A, Annala A, Nhuyen K, Leahy R, et al. Comparison of 3-D maximum a posteriori and filtered backprojection algorithms for high-resolution animal imaging with microPET. IEEE Trans Med Imaging. 2000;19(5):507–512
  37. Levin CS, Hoffman EJ. Calculation of positron range and its effect on the fundamental limit of positron emission tomography system spatial resolution. Phys Med Biol. 1999;44:781
  38. Miller TR, Grigsby PW. Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy. Int J Radiat Oncol Biol Phys. 2002;53(2):353–359
  39. Ford EC, Kinahan PE, Hanlon L, Alessio A, Rajendran J, Schwartz DL, et al. Tumor delineation using PET in head and neck cancers: threshold contouring and lesion volumes. Med Phys. 2006;33(11):4280–4288
  40. El Naqa I, Low DA, Bradley JD, Vicic M, Deasy JO. Deblurring of breathing motion artifacts in thoracic PET images by deconvolution methods. Med Phys. 2006;33(10):3587–3600

PII: S0969-8051(09)00042-0

doi: 10.1016/j.nucmedbio.2009.01.019

Nuclear Medicine and Biology
Volume 36, Issue 5 , Pages 551-559 , July 2009

Article Tools

* Image Usage & Resolution